Saurabh Saha, Chief Executive Officer at Centessa Pharmaceuticals plc (CNTA), sold 12,518 shares at $12.32 ($154K) on 2024-08-20, disclosed to the SEC on 2024-08-22.
Scheduled sale ($154k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.32 | 4,169 | $51K | 33.4% |
| 2 | $12.32 | 4,169 | $51K | 33.4% |
| 3 | $12.25 | 3,674 | $45K | 29.2% |
| 4 | $12.23 | 506 | $6K | 4.0% |
| Total | $12.30 avg | 12,518 | $154K | 100% |
| Filing → |
| CNTA | SELL | 2025-05-20 | $699K | — | Filing → |
| CNTA | SELL | 2025-04-22 | $1.4M | — | Filing → |
| CNTA | SELL | 2025-03-21 | $1.8M | — | Filing → |